Article: New agents expand therapeutic options for ocular allergy

Significant advances in the field of ocular allergy continue to emerge, as evidenced in newly introduced and possible future therapies. For seasonal allergy sufferers, the release of olopatadine hydrochloride (Patanol,Alcon) has been a major therapeutic advance, agree experts in this area. In addition to blocking H1 receptors in the conjunctiva, this agent has been shown to have mast cell stabilizing properties, explained Michael Raizman, MD, who is medical director, cornea service, New England Eye Center, Boston.

"This combined activity has been particularly beneficial for patients because they get the desired rapid symptomatic relief from blockade of histamine binding.The property of ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!